• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠体内三种局部麻醉药(布比卡因、依替卡因和甲哌卡因)的昼夜节律相位依赖性蛋白及组织结合:其时辰毒代动力学的一种可能机制?

Circadian phase-dependent protein and tissular binding of three local anesthetics (bupivacaine, etidocaine, and mepivacaine) in mice: a possible mechanism of their chronotoxicokinetics?

作者信息

Bruguerolle B, Prat M

机构信息

Medical Pharmacology Laboratory, Faculty of Medicine, Marseille, France.

出版信息

Chronobiol Int. 1992 Dec;9(6):448-52. doi: 10.3109/07420529209064558.

DOI:10.3109/07420529209064558
PMID:1473199
Abstract

The aim of this study was to investigate the possible influence of the time of administration on bupivacaine (B), etidocaine (E), and mepivacaine (M) protein and tissue (brain and heart) binding. For each anesthetic agent, a single dose of B (20 mg/kg), E (40 mg/kg), or M (60 mg/kg) was administered intraperitoneally at 10:00, 16:00, 22:00, and 04:00 h. Blood and tissue samples were collected 15 min after drug administration. This study documents significant circadian variations in protein and tissue binding of the three local anesthetic agents. We did not demonstrate a temporal relationship between the respective free and tissue levels. Thus, the temporal variations of free plasma, brain, and heart levels do not seem to be involved in the temporal changes of induced mortality.

摘要

本研究的目的是调查给药时间对布比卡因(B)、依替卡因(E)和甲哌卡因(M)蛋白质及组织(脑和心脏)结合的可能影响。对于每种麻醉剂,在10:00、16:00、22:00和04:00时腹腔注射单剂量的B(20mg/kg)、E(40mg/kg)或M(60mg/kg)。给药后15分钟采集血液和组织样本。本研究记录了三种局部麻醉剂蛋白质及组织结合的显著昼夜变化。我们未证明各自游离水平与组织水平之间存在时间关系。因此,游离血浆、脑和心脏水平的时间变化似乎与诱导死亡率的时间变化无关。

相似文献

1
Circadian phase-dependent protein and tissular binding of three local anesthetics (bupivacaine, etidocaine, and mepivacaine) in mice: a possible mechanism of their chronotoxicokinetics?小鼠体内三种局部麻醉药(布比卡因、依替卡因和甲哌卡因)的昼夜节律相位依赖性蛋白及组织结合:其时辰毒代动力学的一种可能机制?
Chronobiol Int. 1992 Dec;9(6):448-52. doi: 10.3109/07420529209064558.
2
Temporal variations in the erythrocyte permeability to bupivacaine, etidocaine and mepivacaine in mice.小鼠红细胞对布比卡因、依替卡因和甲哌卡因通透性的时间变化。
Life Sci. 1989;45(26):2587-90. doi: 10.1016/0024-3205(89)90243-9.
3
Alterations in the pharmacokinetic properties of amide local anaesthetics following local anaesthetic induced convulsions.局部麻醉诱导惊厥后酰胺类局部麻醉药药代动力学特性的改变。
Acta Anaesthesiol Scand. 1988 Oct;32(7):522-9. doi: 10.1111/j.1399-6576.1988.tb02779.x.
4
Amide local anesthetic alterations of effective refractory period temporal dispersion: relationship to ventricular arrhythmias.酰胺类局部麻醉药对有效不应期时间离散度的影响:与室性心律失常的关系。
Anesthesiology. 1986 Jul;65(1):61-6. doi: 10.1097/00000542-198607000-00010.
5
Circadian phase dependent acute toxicity and pharmacokinetics of etidocaine in serum and brain of mice.依替卡因在小鼠血清和脑中的昼夜节律相依赖性急性毒性及药代动力学
J Pharm Pharmacol. 1990 Mar;42(3):201-2. doi: 10.1111/j.2042-7158.1990.tb05387.x.
6
[Pharmacokinetics of local anesthetics of the amide type].[酰胺类局部麻醉药的药代动力学]
Cah Anesthesiol. 1985 Oct;33(6):501-7.
7
Clinical pharmacokinetics of local anaesthetics.局部麻醉药的临床药代动力学
Clin Pharmacokinet. 1979 Jul-Aug;4(4):241-78. doi: 10.2165/00003088-197904040-00001.
8
Local anesthetic-induced toxicity may be modified by low doses of flumazenil.低剂量氟马西尼可改变局部麻醉药引起的毒性。
Life Sci. 1992;51(25):I-IV. doi: 10.1016/0024-3205(92)90121-5.
9
[Diaplacentar transfer of local anaesthetics (author's transl)].局部麻醉药的胎盘转运(作者译)
Prakt Anaesth. 1978 Feb;13(1):1-6.
10
Clinical pharmacokinetics in pregnancy and perinatology. I. Placental transfer and fetal side effects of local anaesthetic agents.妊娠与围产医学中的临床药代动力学。I. 局部麻醉药的胎盘转运及对胎儿的副作用。
Dev Pharmacol Ther. 1985;8(3):149-81. doi: 10.1159/000457034.

引用本文的文献

1
Pharmacokinetics of bupivacaine enantiomers in sheep: influence of dosage regimen and study design.
J Pharmacokinet Biopharm. 1994 Dec;22(6):481-98. doi: 10.1007/BF02353791.